I'd be surprised if DECN is NOT working to compete in the

New Post Public Reply Private Reply Replies (1) Message Board
plutonium DirkEaston #7005
480
I'd be surprised if DECN is NOT working to compete in the glucose sensor patch market.

For what its worth, I would be. It is not their area of expertise and they do not have the funds to acquire that expertise which would require at least three research chemists, two advanced development engineers and someone schooled in PMAs.

DECN's best bet is to ignore the noise generated on message boards and proceed doing what they appear to do best, creating much better mouse-traps using their advanced technology and get to market first.

It is probably lost on people that DECN inherited a decent idea but a mess from the corrupt Shasta Technologies, and has turned the company into a development company through being nimble, timely, and tough as nails. They have mixed their ability to create finished products with the ability to improve on existing legacy products. They drive legacy manufacturers crazy which is a good thing, but their penny trader shareholder base hurts the company by attacking the company at every opportunity over stock price. This is not lost on potential partners and the large companies DECN needs to curry favor with.

All in all, if DECN had some really $$ they could become a real force. But sadly they are stuck in a stock price is everything and the only thing mode of operation which will most likely lead to some sort of licensing agreements and/or M&A transaction, which in and of themselves will lead to DECN leaving a lot of money on the table, and continued animosity from outsiders.
2

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gnosis Lab's Grand Re-Opening: A New Era for Diagnostics

Updated Category News Views 260

Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...

Continue Reading
New Propane Contract Boosts Titan NRG (TTNN) Growth

Updated Category Stocks Views 404

Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...

Continue Reading
Bitcoin Price Decline: Impact of DOJ and Economic Conditions

Updated Category News Views 259

Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...

Continue Reading
Cogitate and One Inc Team Up to Revolutionize Payments

Updated Category News Views 169

Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...

Continue Reading
Alnylam Pharmaceuticals Achieves New Stock Milestone of $287.88

Updated Category News Views 74

Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...

Continue Reading